Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1075-1081

  Luo, Tao ^a   Zhao, Ming ^b   Li, Xia ^a   Xu, Peng ^b   Gui, Xiaohong ^b   Pickerill, Sam ^a   DeRiemer, Kathryn ^c   Mei, Jian ^b   Gao, Qian ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHINA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SENSITIVITY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CHINA; COHORT STUDIES; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77149123612     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00964-09     Document Type: Article

References (44)

1. Afanas'ev, M. V., L. N. Ikryannikova, E. N. Il'ina, S. V. Sidorenko, A. V. Kuz'min, E. E. Larionova, T. G. Smirnova, L. N. Chernousova, E. Y. Kamaev, S. N. Skorniakov, V. N. Kinsht, A. G. Cherednichenko, and V. M. Govorun. 2007. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J. Antimicrob. Chemother. 59:1057-1064.
2. Andrews, J. R., N. R. Gandhi, P. Moodley, N. S. Shah, L. Bohlken, A. P. Moll, M. Pillay, G. Friedland, and A. W. Sturm. 2008. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. J. Infect. Dis. 198:1582-1589.
3. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
4. Caws, M., P. M. Duy, D. Q. Tho, N. T. Lan, D. V. Hoa, and J. Farrar. 2006. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J. Clin. Microbiol. 44:2333-2337.
5. Chan, R. C., M. Hui, E. W. Chan, T. K. Au, M. L. Chin, C. K. Yip, C. K. AuYeang, C. Y. Yeung, K. M. Kam, P. C. Yip, and A. F. Cheng. 2007. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother. 59:866-873.
6. Chen, J., A. G. Tsolaki, X. Shen, X. Jiang, J. Mei, and Q. Gao. 2007. Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/ W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 87:446-449.
7. Dye, C., and B. G. Williams. 2000. Criteria for the control of drug-resistant tuberculosis. Proc. Natl. Acad. Sci. USA 97:8180-8185.
8. Canetti, G., W. Fox, A. Khomenko, H. T. Mahler, N. K. Menon, D. A. Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. W. H. O. 41:21-43.
9. Gagneux, S., C. D. Long, P. M. Small, T. Van, G. K. Schoolnik, and B. J. Bohannan. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946.
10. Gagneux, S., M. V. Burgos, K. DeRiemer, A. Encisco, S. Munoz, P. C. Hopewell, P. M. Small, and A. S. Pym. 2006. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog. 2:e61.
11. Garcia de Viedma, D. 2003. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin. Microbiol. Infect. 9:349-359.
12. Hazbon, M. H., M. Bobadilla del Valle, M. I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Safi, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, A. Davidow, M. Brimacombe, C. I. Leon, T. Porras, M. Bose, F. Chaves, K. D. Eisenach, J. Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, and D. Alland. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49:3794-3802.
13. Hazbon, M. H., A. S. Motiwala, M. Cavatore, M. Brimacombe, T. S. Whittam, and D. Alland. 2008. Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 52:3369-3376.
14. He, G. X., Y. L. Zhao, G. L. Jiang, Y. H. Liu, H. Xia, S. F. Wang, L. X. Wang, M. W. Borgdorff, M. J. van der Werf, and S. van den Hof. 2008. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect. Dis. 8:166.
15. Iwamoto, T., S. Yoshida, K. Suzuki, and T. Wada. 2008. Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrob. Agents Chemother. 52:3805-3809.
16. Jiao, W. W., I. Mokrousov, G. Z. Sun, M. Li, J. W. Liu, O. Narvskaya, and A. D. Shen. 2007. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin. Med. J. 120:814-819.
17. Kelley, C. L., D. A. Rouse, and S. L. Morris. 1997. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:2057-2058.
18. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. Department of Health and Human Services/ Public Health Service/Centers for Disease Control, Atlanta, GA.
19. Li, X., Y. Zhang, X. Shen, G. Shen, X. Gui, B. Sun, J. Mei, K. Deriemer, P. M. Small, and Q. Gao. 2007. Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J. Infect. Dis. 195:864-869.
20. Ling, D. I., A. A. Zwerling, and M. Pai. 2008. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32:1165-1174.
21. Mokrousov, I., H. M. Ly, T. Otten, N. N. Lan, B. Vyshnevskyi, S. Hoffner, and O. Narvskaya. 2005. Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. Genome Res. 15:1357-1364.
22. Morgan, M., S. Kalantri, L. Flores, and M. Pai. 2005. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 5:62.
23. Morlock, G. P., B. Metchock, D. Sikes, J. T. Crawford, and R. C. Cooksey. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47:3799-3805.
24. Parra, C. A., L. P. Londono, P. Del Portillo, and M. E. Patarroyo. 1991. Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence. Infect. Immun. 59:3411-3417.
25. Pym, A. S., B. Saint-Joanis, and S. T. Cole. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70:4955-4960.
26. Rinder, H., A. Thomschke, S. Rusch-Gerdes, G. Bretzel, K. Feldmann, M. Rifai, and T. Loscher. 1998. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 17:508-511.
27. Sandgren, A., M. Strong, P. Muthukrishnan, B. K. Weiner, G. M. Church, and M. B. Murray. 2009. Tuberculosis drug resistance mutation database. PLoS Med. 6:e2.
28. Shen, G. M., J. Zha, L. Xu, B. Sun, X. H. Gui, Y. F. Wang, J. Mei, and Q. Gao. 2005. Evaluation of the mycobacterial interspersed repetitive units typing as a practical approach in molecular epidemiology of Mycobacterium tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 28:292-296.
29. Shen, X., K. DeRiemer, Z. A. Yuan, M. Shen, Z. Xia, X. Gui, L. Wang, Q. Gao, and J. Mei. 2009. Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors. Int. J. Tuber. Lung Dis. 13:253-259.
30. Shen, X., G. M. Shen, J. Wu, X. H. Gui, X. Li, J. Mei, K. DeRiemer, and Q. Gao. 2007. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51: 2618-2620.
31. Sherman, D. R., K. Mdluli, M. J. Hickey, T. M. Arain, S. L. Morris, C. E. Barry, and C. K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272:1641-1643.
32. Silva, M. S., S. G. Senna, M. O. Ribeiro, A. R. Valim, M. A. Telles, A. Kritski, G. P. Morlock, R. C. Cooksey, A. Zaha, and M. L. Rossetti. 2003. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 41:4471-4474.
33. Slayden, R. A., and C. E. Barry III. 2000. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect. 2:659-669.
34. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
35. Tsolaki, A. G., S. Gagneux, A. S. Pym, Y. O. Goguet de la Salmoniere, B. N. Kreiswirth, D. Van Soolingen, and P. M. Small. 2005. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J. Clin. Microbiol. 43:3185-3191.
36. Van Rie, A., R. Warren, I. Mshanga, A. M. Jordaan, G. D. van der Spuy, M. Richardson, J. Simpson, R. P. Gie, D. A. Enarson, N. Beyers, P. D. van Helden, and T. C. Victor. 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39:636-641.
37. Wade, M. M., and Y. Zhang. 2004. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front. Biosci. 9:975-994.
38. WHO. 2008. Anti-tuberculosis drug resistance in the world: the 320 WHO/ IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (WHO/HTM/TB/2008.394). World Health Organization, Geneva, Switzerland.
39. WHO. 2009. Global tuberculosis control report (WHO/HTM/TB/2009. 411). World Health Organization, Geneva, Switzerland.
40. Zhang, L., J. Chen, X. Shen, X. Gui, J. Mei, K. Deriemer, and Q. Gao. 2008. Highly polymorphic variable-number tandem repeats loci for differentiating Beijing genotype strains of Mycobacterium tuberculosis in Shanghai, China. FEMS Microbiol. Lett. 282:22-31.
41. Zhang, M., J. Yue, Y. P. Yang, H. M. Zhang, J. Q. Lei, R. L. Jin, X. L. Zhang, and H. H. Wang. 2005. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 43:5477-5482.
42. Zhang, S. L., H. Qi, D. L. Qiu, D. X. Li, J. Zhang, C. M. Du, G. B. Wang, Z. R. Yang, and Q. Sun. 2007. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates recovered from central China. Biochem. Genet. 45:281-290.
43. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalaseperoxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.
44. Zhao, M., X. Li, P. Xu, X. Shen, X. Gui, L. Wang, K. Deriemer, J. Mei, and Q. Gao. 2009. Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One 4:e4370.